Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF - PubMed (original) (raw)

doi: 10.1038/nn1653. Epub 2006 Feb 12.

Affiliations

PMID: 16474388
DOI: 10.1038/nn1653

Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF

San Pun et al. Nat Neurosci. 2006 Mar.

Abstract

Neurodegenerative diseases can have long preclinical phases and insidious progression patterns, but the mechanisms of disease progression are poorly understood. Because quantitative accounts of neuronal circuitry affected by disease have been lacking, it has remained unclear whether disease progression reflects processes of stochastic loss or temporally defined selective vulnerabilities of distinct synapses or axons. Here we derive a quantitative topographic map of muscle innervation in the hindlimb. We show that in two mouse models of motoneuron disease (G93A SOD1 and G85R SOD1), axons of fast-fatiguable motoneurons are affected synchronously, long before symptoms appear. Fast-fatigue-resistant motoneuron axons are affected at symptom-onset, whereas axons of slow motoneurons are resistant. Axonal vulnerability leads to synaptic vesicle stalling and accumulation of BC12a1-a, an anti-apoptotic protein. It is alleviated by ciliary neurotrophic factor and triggers proteasome-dependent pruning of peripheral axon branches. Thus, motoneuron disease involves predictable, selective vulnerability patterns by physiological subtypes of axons, episodes of abrupt pruning in the target region and compensation by resistant axons.

PubMed Disclaimer

Cited by

Endomicroscopy and electromyography of neuromuscular junctions in situ.
Brown R, Dissanayake KN, Skehel PA, Ribchester RR. Brown R, et al. Ann Clin Transl Neurol. 2014 Nov;1(11):867-83. doi: 10.1002/acn3.124. Epub 2014 Oct 10. Ann Clin Transl Neurol. 2014. PMID: 25540801 Free PMC article.
Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis.
Rué L, Timmers M, Lenaerts A, Smolders S, Poppe L, de Boer A, Van Den Bosch L, Van Damme P, Robberecht W, Lemmens R. Rué L, et al. Sci Rep. 2019 Oct 1;9(1):14112. doi: 10.1038/s41598-019-50615-0. Sci Rep. 2019. PMID: 31575928 Free PMC article.
Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of amyotrophic lateral sclerosis.
Hur SK, Hunter M, Dominique MA, Farag M, Cotton-Samuel D, Khan T, Trojanowski JQ, Spiller KJ, Lee VM. Hur SK, et al. Acta Neuropathol Commun. 2022 May 14;10(1):75. doi: 10.1186/s40478-022-01373-0. Acta Neuropathol Commun. 2022. PMID: 35568882 Free PMC article.
Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo.
Dermentzaki G, Politi KA, Lu L, Mishra V, Pérez-Torres EJ, Sosunov AA, McKhann GM 2nd, Lotti F, Shneider NA, Przedborski S. Dermentzaki G, et al. eNeuro. 2019 Feb 19;6(1):ENEURO.0308-18.2018. doi: 10.1523/ENEURO.0308-18.2018. eCollection 2019 Jan-Feb. eNeuro. 2019. PMID: 30815534 Free PMC article.
Synaptic restoration by cAMP/PKA drives activity-dependent neuroprotection to motoneurons in ALS.
Bączyk M, Alami NO, Delestrée N, Martinot C, Tang L, Commisso B, Bayer D, Doisne N, Frankel W, Manuel M, Roselli F, Zytnicki D. Bączyk M, et al. J Exp Med. 2020 Aug 3;217(8):e20191734. doi: 10.1084/jem.20191734. J Exp Med. 2020. PMID: 32484501 Free PMC article.

Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF - PubMed (original) (raw)